Vivoryon Therapeutics N.V.: Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clini

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous28.02.2022 / 01:00 The issuer is solely responsible for the content of this announcement.Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with Alzheimer's Dis...

Related Keywords

China ,Germany ,Nanjing ,Jiangsu ,Renhong Tang ,Jason Bao ,Sophia Hergenhan ,Manuela Bader ,Jian Hou ,Michael Schaeffer ,Simcere Pharmaceutical Group ,National Medical Products Administration ,Drug Administration ,Trophic Communications ,Simcere Pharmaceutical Group Ltd ,China Center ,Distribution Services ,Simcere Announce ,Chinese Clinical Trial Application ,Euronext Amsterdam ,Drug Evaluation ,Clinical Trial Application ,Greater China ,Executive Vice President ,Chief Business Officer ,Fast Track ,Pharmaceutical Group ,Simcere Pharmaceutical Group Limited ,Board Secretary ,Corporate News ,Regulatory Announcements ,